What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2017 Referencia Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.lungcan.2017.07.021 Revista LUNG CANCER Títol Complet Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Factor d'impacte 4.29 Autors Irene Sansano Valero Codi 9390 PMID https://pubmed.ncbi.nlm.nih.gov/28838386 Nom Autors Verbeken, Eric K, Warth, Arne, Sansano, Irene, Cheney, Richard, Speel, Ernst Jan M, Nonaka, Daisuke, Monkhorst, Kim, Hager, Henrik, Martorell, Miguel, Savic, Spasenija et al. DOI número 10.1016/j.lungcan.2017.07.021 Year 2017 Referencia Clin Breast Cancer. 2017 Dec;17(8):585-594.e4. doi: 10.1016/j.clbc.2017.05.006. Epub 2017 May 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.clbc.2017.05.006 Revista Clinical Breast Cancer Títol Complet RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. Factor d'impacte 2.82 Codi 9391 PMID https://pubmed.ncbi.nlm.nih.gov/28830796 Nom Autors Baselga, Jose, Zamagni, Claudio, Gomez, Patricia, Bermejo, Begona, Nagai, Shigenori E, Melichar, Bohuslav, Chan, Arlene, Mangel, Laszlo, Bergh, Jonas, Costa, Frederico et al. DOI número 10.1016/j.clbc.2017.05.006 Year 2017 Referencia J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.1076 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA. Factor d'impacte 24.01 Codi 9392 PMID https://pubmed.ncbi.nlm.nih.gov/28809610 Nom Autors Zhang, Wenping, Bernard, John, de Bono, Johann, Chadjaa, Mustapha, Kacso, Gabriel, Font, Albert, Parente, Phillip, Eisenberger, Mario, Hardy-Bessard, Anne-Claire, Kim, Choung Soo et al. DOI número 10.1200/JCO.2016.72.1076 Year 2017 Referencia Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(17)30450-3 Revista LANCET ONCOLOGY Títol Complet Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Factor d'impacte 33.90 Codi 9393 PMID https://pubmed.ncbi.nlm.nih.gov/28800861 Nom Autors Espie, Marc, Kim, Sung-Bae, Dent, Rebecca, Im, Seock-Ah, Espie, Marc, Blau, Sibel, Tan, Antoinette R, Isakoff, Steven J, Oliveira, Mafalda, Saura, Cristina et al. DOI número 10.1016/S1470-2045(17)30450-3 Year 2017 Referencia J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2017.73.3402 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma. Factor d'impacte 24.01 Codi 9394 PMID https://pubmed.ncbi.nlm.nih.gov/28796588 Nom Autors Vitolo, Umberto, Trneny, Marek, Belada, David, Burke, John M, Carella, Angelo Michele, Chua, Neil, Abrisqueta, Pau, Demeter, Judit, Flinn, Ian, Hong, Xiaonan et al. DOI número 10.1200/JCO.2017.73.3402 Year 2017 Referencia Sci Rep. 2017 Aug 9;7(1):7687. doi: 10.1038/s41598-017-08048-0. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-08048-0 Revista Scientific Reports Títol Complet Prognostic impact of CD133 expression in Endometrial Cancer Patients. Factor d'impacte 4.26 Codi 9395 PMID https://pubmed.ncbi.nlm.nih.gov/28794448 Nom Autors Mancebo, G, Sole-Sedeno, J M, Pino, O, Miralpeix, E, Mojal, S, Garrigos, L, Lloveras, B, Navarro, P, Gibert, J, Lorenzo, M et al. DOI número 10.1038/s41598-017-08048-0 Year 2017 Referencia Br J Cancer. 2017 Sep 5;117(6):767-774. doi: 10.1038/bjc.2017.252. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.252 Revista BRITISH JOURNAL OF CANCER Títol Complet GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS). Factor d'impacte 6.18 Codi 9396 PMID https://pubmed.ncbi.nlm.nih.gov/28787430 Nom Autors Maradiegue, E, Valverde, C, Martin-Broto, J, Garcia Del Muro, X, Cruz, O, Cruz, J, Martinez-Trufero, J, Maurel, J, Vaz, M A, de Alava, E et al. DOI número 10.1038/bjc.2017.252 Year 2017 Referencia Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1634/theoncologist.2016-0178 Revista ONCOLOGIST Títol Complet Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Factor d'impacte 4.96 Codi 9397 PMID https://pubmed.ncbi.nlm.nih.gov/28778958 Nom Autors Spindler, Karen-Lise G, Boysen, Anders K, Pallisgard, Niels, Johansen, Julia S, Tabernero, Josep, Sorensen, Morten M, Jensen, Benny V, Hansen, Torben F, Sefrioui, David, Andersen, Rikke F et al. DOI número 10.1634/theoncologist.2016-0178 Year 2017 Referencia Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)31607-0 Revista LANCET Títol Complet Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Factor d'impacte 47.83 Codi 9398 PMID https://pubmed.ncbi.nlm.nih.gov/28756902 Nom Autors Monk, Bradley J, Sill, Michael W, Penson, Richard T, Huang, Helen, Ramondetta, Lois M, Landrum, Lisa M, Oaknin, Ana, Reid, Thomas J, Leitao, Mario M, Michael, Helen E et al. DOI número 10.1016/S0140-6736(17)31607-0 Year 2017 Referencia Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s10549-017-4405-3 Revista BREAST CANCER RESEARCH AND TREATMENT Títol Complet Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Factor d'impacte 3.63 Codi 9399 PMID https://pubmed.ncbi.nlm.nih.gov/28755147 Nom Autors Rubio, I T, Benson, J, Douek, M, Baker, R, Jozsa, F, Ahmed, Muneer et al. DOI número 10.1007/s10549-017-4405-3 Year 2017 Referencia Haematologica. 2017 Oct;102(10):1776-1784. doi: 10.3324/haematol.2017.164632. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3324/haematol.2017.164632 Revista HAEMATOLOGICA Títol Complet The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling. Factor d'impacte 7.70 Codi 9400 PMID https://pubmed.ncbi.nlm.nih.gov/28751557 Nom Autors Diaz, Tania, Rodriguez, Vanina, Lozano, Ester, Mena, Mari-Pau, Calderon, Marcos, Rosinol, Laura, Martinez, Antonio, Tovar, Natalia, Perez-Galan, Patricia, Blade, Joan et al. DOI número 10.3324/haematol.2017.164632 Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Sep;80(3):599-608. doi: 10.1007/s00280-017-3380-z. Epub 2017 Jul 25. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3380-z Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. Factor d'impacte 2.74 Codi 9401 PMID https://pubmed.ncbi.nlm.nih.gov/28744667 Nom Autors Cohn, Allen Lee, Yoshino, Takayuki, Heinemann, Volker, Obermannova, Radka, Bodoky, Gyorgy, Prausova, Jana, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Garcia-Alfonso, Pilar, Portnoy, David C et al. DOI número 10.1007/s00280-017-3380-z Year 2017 Referencia Nature. 2017 Aug 3;548(7665):40-41. doi: 10.1038/nature23101. Epub 2017 Jul 19. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1038/nature23101 Revista NATURE Títol Complet Cancer: A precision approach to tumour treatment. Factor d'impacte 40.14 Codi 9404 PMID https://pubmed.ncbi.nlm.nih.gov/28723897 Nom Autors Dienstmann, Rodrigo, Tabernero, Josep et al. DOI número 10.1038/nature23101 Year 2017 Referencia Mol Cancer Ther. 2017 Oct;16(10):2215-2222. doi: 10.1158/1535-7163.MCT-16-0895. Epub 2017 Jul 17. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1535-7163.MCT-16-0895 Revista MOLECULAR CANCER THERAPEUTICS Títol Complet Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer. Factor d'impacte 5.76 Codi 9405 PMID https://pubmed.ncbi.nlm.nih.gov/28716815 Nom Autors Tomasek, Jiri, Safran, Howard, Chandrawansa, Kumari, Hsu, Yanzhi, Heathman, Michael, Khan, Azhar, Ni, Lan, Melemed, Allen S, Gao, Ling, Ferry, David et al. DOI número 10.1158/1535-7163.MCT-16-0895 Year 2017 Referencia Case Rep Hematol. 2017;2017:4109605. doi: 10.1155/2017/4109605. Epub 2017 Jun 11. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1155/2017/4109605 Revista Case reports in hematology Títol Complet Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain. Codi 9406 PMID https://pubmed.ncbi.nlm.nih.gov/28695025 Nom Autors Mingot-Castellano, Maria-Eva, Grande-Garcia, Carlos, Valcarcel-Ferreiras, David, Conill-Cortes, Clara, de Olivar-Oliver, Loreto et al. DOI número 10.1155/2017/4109605 Year 2017 Referencia Cancer Discov. 2017 Jul;7(7):666-669. doi: 10.1158/2159-8290.CD-17-0500. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1158/2159-8290.CD-17-0500 Revista Cancer Discovery Títol Complet Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness. Factor d'impacte 20.01 Codi 9407 PMID https://pubmed.ncbi.nlm.nih.gov/28684409 Nom Autors Rodon, Jordi, Tabernero, Josep et al. DOI número 10.1158/2159-8290.CD-17-0500 Year 2017 Referencia Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s12094-017-1700-8 Revista Clinical & Translational Oncology Títol Complet Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database. Factor d'impacte 2.35 Codi 9408 PMID https://pubmed.ncbi.nlm.nih.gov/28660482 Nom Autors de Castro, J, Remon, J, Isla, D, Garrido, P, Artal, A, Carcereny, E, Garcia-Campelo, M R, Lianes, P, Provencio, M, Juan, O et al. DOI número 10.1007/s12094-017-1700-8 Year 2017 Referencia J Clin Oncol. 2017 Sep 20;35(27):3113-3122. doi: 10.1200/JCO.2016.72.0946. Epub 2017 Jun 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.0946 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. Factor d'impacte 24.01 Codi 9409 PMID https://pubmed.ncbi.nlm.nih.gov/28654365 Nom Autors Bellet, Meritxell, Perello, Antonia, Dane, Faysal, Moreira, Antonio, Vorobiof, Daniel, Nottage, Michelle, Price, Karen N, Coates, Alan S, Goldhirsch, Aron, Gelber, Richard D et al. DOI número 10.1200/JCO.2016.72.0946 Year 2017 Referencia Eur J Cancer. 2017 Sep;82:16-24. doi: 10.1016/j.ejca.2017.04.025. Epub 2017 Jun 23. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ejca.2017.04.025 Revista EUROPEAN JOURNAL OF CANCER Títol Complet Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. Factor d'impacte 6.03 Codi 9410 PMID https://pubmed.ncbi.nlm.nih.gov/28651158 Nom Autors Nielsen, Svend Erik, Emile, Jean-Francois, Julie, Catherine, Le Malicot, Karine, Lepage, Come, Tabernero, Josep, Mini, Enrico, Folprecht, Gunnar, Van Laethem, Jean-Luc, Dimet, Stephanie et al. DOI número 10.1016/j.ejca.2017.04.025 Year 2017 Referencia J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jhep.2017.06.010 Revista JOURNAL OF HEPATOLOGY Títol Complet Alfapump(R) system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. Factor d'impacte 12.49 Autors Macarena Simon-Talero Horga Codi 9411 PMID https://pubmed.ncbi.nlm.nih.gov/28645737 Nom Autors Bureau, Christophe, Adebayo, Danielle, Chalret de Rieu, Mael, Elkrief, Laure, Valla, Dominique, Peck-Radosavljevic, Markus, McCune, Anne, Vargas, Victor, Simon-Talero, Macarena, Cordoba, Juan et al. DOI número 10.1016/j.jhep.2017.06.010 Pagination First page « Previous page ‹ … Page 735 Page 736 Current page 737 Page 738 Page 739 … Next page › Last page »
Year 2017 Referencia Lung Cancer. 2017 Sep;111:143-149. doi: 10.1016/j.lungcan.2017.07.021. Epub 2017 Jul 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.lungcan.2017.07.021 Revista LUNG CANCER Títol Complet Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Factor d'impacte 4.29 Autors Irene Sansano Valero Codi 9390 PMID https://pubmed.ncbi.nlm.nih.gov/28838386 Nom Autors Verbeken, Eric K, Warth, Arne, Sansano, Irene, Cheney, Richard, Speel, Ernst Jan M, Nonaka, Daisuke, Monkhorst, Kim, Hager, Henrik, Martorell, Miguel, Savic, Spasenija et al. DOI número 10.1016/j.lungcan.2017.07.021
Year 2017 Referencia Clin Breast Cancer. 2017 Dec;17(8):585-594.e4. doi: 10.1016/j.clbc.2017.05.006. Epub 2017 May 22. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.clbc.2017.05.006 Revista Clinical Breast Cancer Títol Complet RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer. Factor d'impacte 2.82 Codi 9391 PMID https://pubmed.ncbi.nlm.nih.gov/28830796 Nom Autors Baselga, Jose, Zamagni, Claudio, Gomez, Patricia, Bermejo, Begona, Nagai, Shigenori E, Melichar, Bohuslav, Chan, Arlene, Mangel, Laszlo, Bergh, Jonas, Costa, Frederico et al. DOI número 10.1016/j.clbc.2017.05.006
Year 2017 Referencia J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.1076 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA. Factor d'impacte 24.01 Codi 9392 PMID https://pubmed.ncbi.nlm.nih.gov/28809610 Nom Autors Zhang, Wenping, Bernard, John, de Bono, Johann, Chadjaa, Mustapha, Kacso, Gabriel, Font, Albert, Parente, Phillip, Eisenberger, Mario, Hardy-Bessard, Anne-Claire, Kim, Choung Soo et al. DOI número 10.1200/JCO.2016.72.1076
Year 2017 Referencia Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S1470-2045(17)30450-3 Revista LANCET ONCOLOGY Títol Complet Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Factor d'impacte 33.90 Codi 9393 PMID https://pubmed.ncbi.nlm.nih.gov/28800861 Nom Autors Espie, Marc, Kim, Sung-Bae, Dent, Rebecca, Im, Seock-Ah, Espie, Marc, Blau, Sibel, Tan, Antoinette R, Isakoff, Steven J, Oliveira, Mafalda, Saura, Cristina et al. DOI número 10.1016/S1470-2045(17)30450-3
Year 2017 Referencia J Clin Oncol. 2017 Nov 1;35(31):3529-3537. doi: 10.1200/JCO.2017.73.3402. Epub 2017 Aug 10. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2017.73.3402 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma. Factor d'impacte 24.01 Codi 9394 PMID https://pubmed.ncbi.nlm.nih.gov/28796588 Nom Autors Vitolo, Umberto, Trneny, Marek, Belada, David, Burke, John M, Carella, Angelo Michele, Chua, Neil, Abrisqueta, Pau, Demeter, Judit, Flinn, Ian, Hong, Xiaonan et al. DOI número 10.1200/JCO.2017.73.3402
Year 2017 Referencia Sci Rep. 2017 Aug 9;7(1):7687. doi: 10.1038/s41598-017-08048-0. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/s41598-017-08048-0 Revista Scientific Reports Títol Complet Prognostic impact of CD133 expression in Endometrial Cancer Patients. Factor d'impacte 4.26 Codi 9395 PMID https://pubmed.ncbi.nlm.nih.gov/28794448 Nom Autors Mancebo, G, Sole-Sedeno, J M, Pino, O, Miralpeix, E, Mojal, S, Garrigos, L, Lloveras, B, Navarro, P, Gibert, J, Lorenzo, M et al. DOI número 10.1038/s41598-017-08048-0
Year 2017 Referencia Br J Cancer. 2017 Sep 5;117(6):767-774. doi: 10.1038/bjc.2017.252. Epub 2017 Aug 8. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1038/bjc.2017.252 Revista BRITISH JOURNAL OF CANCER Títol Complet GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS). Factor d'impacte 6.18 Codi 9396 PMID https://pubmed.ncbi.nlm.nih.gov/28787430 Nom Autors Maradiegue, E, Valverde, C, Martin-Broto, J, Garcia Del Muro, X, Cruz, O, Cruz, J, Martinez-Trufero, J, Maurel, J, Vaz, M A, de Alava, E et al. DOI número 10.1038/bjc.2017.252
Year 2017 Referencia Oncologist. 2017 Sep;22(9):1049-1055. doi: 10.1634/theoncologist.2016-0178. Epub 2017 Aug 4. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1634/theoncologist.2016-0178 Revista ONCOLOGIST Títol Complet Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Factor d'impacte 4.96 Codi 9397 PMID https://pubmed.ncbi.nlm.nih.gov/28778958 Nom Autors Spindler, Karen-Lise G, Boysen, Anders K, Pallisgard, Niels, Johansen, Julia S, Tabernero, Josep, Sorensen, Morten M, Jensen, Benny V, Hansen, Torben F, Sefrioui, David, Andersen, Rikke F et al. DOI número 10.1634/theoncologist.2016-0178
Year 2017 Referencia Lancet. 2017 Oct 7;390(10103):1654-1663. doi: 10.1016/S0140-6736(17)31607-0. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/S0140-6736(17)31607-0 Revista LANCET Títol Complet Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240). Factor d'impacte 47.83 Codi 9398 PMID https://pubmed.ncbi.nlm.nih.gov/28756902 Nom Autors Monk, Bradley J, Sill, Michael W, Penson, Richard T, Huang, Helen, Ramondetta, Lois M, Landrum, Lisa M, Oaknin, Ana, Reid, Thomas J, Leitao, Mario M, Michael, Helen E et al. DOI número 10.1016/S0140-6736(17)31607-0
Year 2017 Referencia Breast Cancer Res Treat. 2017 Nov;166(2):329-336. doi: 10.1007/s10549-017-4405-3. Epub 2017 Jul 28. Tipus publicació Review in international publication DOI http://dx.doi.org/10.1007/s10549-017-4405-3 Revista BREAST CANCER RESEARCH AND TREATMENT Títol Complet Meta-analysis of tumour burden in pre-operative axillary ultrasound positive and negative breast cancer patients. Factor d'impacte 3.63 Codi 9399 PMID https://pubmed.ncbi.nlm.nih.gov/28755147 Nom Autors Rubio, I T, Benson, J, Douek, M, Baker, R, Jozsa, F, Ahmed, Muneer et al. DOI número 10.1007/s10549-017-4405-3
Year 2017 Referencia Haematologica. 2017 Oct;102(10):1776-1784. doi: 10.3324/haematol.2017.164632. Epub 2017 Jul 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.3324/haematol.2017.164632 Revista HAEMATOLOGICA Títol Complet The BET bromodomain inhibitor CPI203 improves lenalidomide and dexamethasone activity in in vitro and in vivo models of multiple myeloma by blockade of Ikaros and MYC signaling. Factor d'impacte 7.70 Codi 9400 PMID https://pubmed.ncbi.nlm.nih.gov/28751557 Nom Autors Diaz, Tania, Rodriguez, Vanina, Lozano, Ester, Mena, Mari-Pau, Calderon, Marcos, Rosinol, Laura, Martinez, Antonio, Tovar, Natalia, Perez-Galan, Patricia, Blade, Joan et al. DOI número 10.3324/haematol.2017.164632
Year 2017 Referencia Cancer Chemother Pharmacol. 2017 Sep;80(3):599-608. doi: 10.1007/s00280-017-3380-z. Epub 2017 Jul 25. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s00280-017-3380-z Revista CANCER CHEMOTHERAPY AND PHARMACOLOGY Títol Complet Exposure-response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial. Factor d'impacte 2.74 Codi 9401 PMID https://pubmed.ncbi.nlm.nih.gov/28744667 Nom Autors Cohn, Allen Lee, Yoshino, Takayuki, Heinemann, Volker, Obermannova, Radka, Bodoky, Gyorgy, Prausova, Jana, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Garcia-Alfonso, Pilar, Portnoy, David C et al. DOI número 10.1007/s00280-017-3380-z
Year 2017 Referencia Nature. 2017 Aug 3;548(7665):40-41. doi: 10.1038/nature23101. Epub 2017 Jul 19. Tipus publicació Editorail in international publication DOI http://dx.doi.org/10.1038/nature23101 Revista NATURE Títol Complet Cancer: A precision approach to tumour treatment. Factor d'impacte 40.14 Codi 9404 PMID https://pubmed.ncbi.nlm.nih.gov/28723897 Nom Autors Dienstmann, Rodrigo, Tabernero, Josep et al. DOI número 10.1038/nature23101
Year 2017 Referencia Mol Cancer Ther. 2017 Oct;16(10):2215-2222. doi: 10.1158/1535-7163.MCT-16-0895. Epub 2017 Jul 17. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1158/1535-7163.MCT-16-0895 Revista MOLECULAR CANCER THERAPEUTICS Títol Complet Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer. Factor d'impacte 5.76 Codi 9405 PMID https://pubmed.ncbi.nlm.nih.gov/28716815 Nom Autors Tomasek, Jiri, Safran, Howard, Chandrawansa, Kumari, Hsu, Yanzhi, Heathman, Michael, Khan, Azhar, Ni, Lan, Melemed, Allen S, Gao, Ling, Ferry, David et al. DOI número 10.1158/1535-7163.MCT-16-0895
Year 2017 Referencia Case Rep Hematol. 2017;2017:4109605. doi: 10.1155/2017/4109605. Epub 2017 Jun 11. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1155/2017/4109605 Revista Case reports in hematology Títol Complet Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain. Codi 9406 PMID https://pubmed.ncbi.nlm.nih.gov/28695025 Nom Autors Mingot-Castellano, Maria-Eva, Grande-Garcia, Carlos, Valcarcel-Ferreiras, David, Conill-Cortes, Clara, de Olivar-Oliver, Loreto et al. DOI número 10.1155/2017/4109605
Year 2017 Referencia Cancer Discov. 2017 Jul;7(7):666-669. doi: 10.1158/2159-8290.CD-17-0500. Tipus publicació Letter or abstract DOI http://dx.doi.org/10.1158/2159-8290.CD-17-0500 Revista Cancer Discovery Títol Complet Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A New Light in the Darkness. Factor d'impacte 20.01 Codi 9407 PMID https://pubmed.ncbi.nlm.nih.gov/28684409 Nom Autors Rodon, Jordi, Tabernero, Josep et al. DOI número 10.1158/2159-8290.CD-17-0500
Year 2017 Referencia Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1007/s12094-017-1700-8 Revista Clinical & Translational Oncology Títol Complet Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database. Factor d'impacte 2.35 Codi 9408 PMID https://pubmed.ncbi.nlm.nih.gov/28660482 Nom Autors de Castro, J, Remon, J, Isla, D, Garrido, P, Artal, A, Carcereny, E, Garcia-Campelo, M R, Lianes, P, Provencio, M, Juan, O et al. DOI número 10.1007/s12094-017-1700-8
Year 2017 Referencia J Clin Oncol. 2017 Sep 20;35(27):3113-3122. doi: 10.1200/JCO.2016.72.0946. Epub 2017 Jun 27. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1200/JCO.2016.72.0946 Revista JOURNAL OF CLINICAL ONCOLOGY Títol Complet Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials. Factor d'impacte 24.01 Codi 9409 PMID https://pubmed.ncbi.nlm.nih.gov/28654365 Nom Autors Bellet, Meritxell, Perello, Antonia, Dane, Faysal, Moreira, Antonio, Vorobiof, Daniel, Nottage, Michelle, Price, Karen N, Coates, Alan S, Goldhirsch, Aron, Gelber, Richard D et al. DOI número 10.1200/JCO.2016.72.0946
Year 2017 Referencia Eur J Cancer. 2017 Sep;82:16-24. doi: 10.1016/j.ejca.2017.04.025. Epub 2017 Jun 23. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.ejca.2017.04.025 Revista EUROPEAN JOURNAL OF CANCER Títol Complet Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. Factor d'impacte 6.03 Codi 9410 PMID https://pubmed.ncbi.nlm.nih.gov/28651158 Nom Autors Nielsen, Svend Erik, Emile, Jean-Francois, Julie, Catherine, Le Malicot, Karine, Lepage, Come, Tabernero, Josep, Mini, Enrico, Folprecht, Gunnar, Van Laethem, Jean-Luc, Dimet, Stephanie et al. DOI número 10.1016/j.ejca.2017.04.025
Year 2017 Referencia J Hepatol. 2017 Nov;67(5):940-949. doi: 10.1016/j.jhep.2017.06.010. Epub 2017 Jun 21. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jhep.2017.06.010 Revista JOURNAL OF HEPATOLOGY Títol Complet Alfapump(R) system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled study. Factor d'impacte 12.49 Autors Macarena Simon-Talero Horga Codi 9411 PMID https://pubmed.ncbi.nlm.nih.gov/28645737 Nom Autors Bureau, Christophe, Adebayo, Danielle, Chalret de Rieu, Mael, Elkrief, Laure, Valla, Dominique, Peck-Radosavljevic, Markus, McCune, Anne, Vargas, Victor, Simon-Talero, Macarena, Cordoba, Juan et al. DOI número 10.1016/j.jhep.2017.06.010
